Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Distinct roles of WHO Score, CCI, and CFS in prognosis and treatment decisions for non-small cell lung cancer: A retrospective real-world study.
Journal: Cancer treatment and research communications
Published: October 02, 2025
Low Risk of Central Nervous System Relapse Among Patients With T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Despite High-Risk Disease Presentation.
Journal: European journal of haematology
Published: June 28, 2025
Impact of Treatment Decisions on Survival Outcomes in Elderly Patients With Non-Small Cell Lung Cancer: A Retrospective Real-World Study.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: April 26, 2025
Outcome of lung cancer surgery and proportion of lung cancer patients eligible for surgery in five Finnish hospitals in 2018, real world study.
Journal: Acta oncologica (Stockholm, Sweden)
Published: March 18, 2025
Prolonged Time From Symptoms to Diagnosis Is Associated With an Inferior Progression-Free Survival in Diffuse Large B-Cell Lymphoma.
Journal: Cancer medicine
Published: March 17, 2025
Favourable Outcome of Relapsed PCNSL Among Transplant Eligble Patients.
Journal: European journal of haematology
Published: September 19, 2024
Defining MRI-based follow-up protocol for primary central nervous system lymphoma.
Journal: Annals of hematology
Published: September 09, 2024
Lifetime Treatment Trajectories of Mantle Cell Lymphoma: Simulation Based Analysis of 20 Years of Real-World Data.
Journal: Hematological oncology
Published: August 11, 2024
Patient's HLA Genotype Is Associated With the Risk of Central Nervous System Dissemination and Clinical Disease Presentation in Diffuse Large B-cell Lymphoma.
Journal: Anticancer research
Published: May 29, 2024
Front-line and second-line treatment for mantle cell lymphoma in clinical practice: A multicenter retrospective analysis.
Journal: European journal of haematology
Published: January 17, 2024
Rapid diagnosis and initiation of treatment has a crucial role in the prognosis of primary central nervous system lymphoma.
Journal: British journal of haematology
Published: April 27, 2023
Real-world Data: MCL2 Protocol Demonstrates Excellent Treatment Results Among Patients With Mantle Cell Lymphoma Not Fulfilling the Original Trial Inclusion Criteria.
Journal: HemaSphere
Published: March 04, 2023
Last Updated: 09/26/2026